As we approach the OPTIONS XII for the Control of Influenza, a global scientific meeting that focuses on influenza, there is an enormous sense of pride among all of us at CSL Seqirus. For ...

Veltassa® offers effective and well-tolerated long-term potassium control in chronic kidney disease and chronic heart failure ...

Approval underscores CSL and Arcturus Therapeutics' commitment to delivering disruptive technologies to combat COVID-19 and other respiratory viral diseases to protect public health KOSTAIVE®, ...

Are you interested in receiving our latest news? Simply fill out the form below to receive news alerts directly to your inbox. To receive releases from a specific CSL business unit, select customize ...

For additional photos, logos and other branding elements, visit Brand.csl.com and Create an Account in the External Users Only box.